Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research note released on Tuesday morning. The firm issued a buy rating on the stock.

Mannatech Trading Down 0.3 %

NASDAQ MTEX opened at $7.86 on Tuesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The firm has a market cap of $14.82 million, a price-to-earnings ratio of -9.70 and a beta of 1.17. The firm has a 50 day simple moving average of $7.84 and a 200-day simple moving average of $7.56. Mannatech has a one year low of $6.75 and a one year high of $10.51.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The business had revenue of $31.73 million during the quarter.

Insider Buying and Selling at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction on Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the completion of the sale, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. The trade was a 22.94 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 41.50% of the stock is owned by corporate insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.